![Vera Goossens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Christiaan de Wilde | M | - |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 18 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Peter Meuris | M | - |
Ghent University
| 1 Jahre |
Paul Magrez | M | - |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 6 Jahre |
Frank Morich | M | 69 |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 2 Jahre |
Wim van Criekinge | M | 53 |
Ghent University
| 8 Jahre |
Werner Cautreels | M | 71 |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 7 Jahre |
Vincent Macharis | M | 52 |
Ghent University
| 2 Jahre |
Rudi Vander Vennet | M | 59 |
Ghent University
| 3 Jahre |
Berg de Bleecker | F | - |
Ghent University
| 5 Jahre |
Yi Ning Zhao | M | 53 |
Ghent University
| 3 Jahre |
Jurgen Timperman | M | 51 |
Ghent University
| - |
Sébastien Vermeire | M | - |
Ghent University
| 1 Jahre |
Michel Baijot | M | - |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 5 Jahre |
Koenraad van Nieuwenburg | M | - |
Ghent University
| 1 Jahre |
Thierry Saegeman | M | - |
Ghent University
| 4 Jahre |
Jan Willems | M | 49 |
Ghent University
| 4 Jahre |
Ilse Irene Henne | F | 51 |
Ghent University
| 4 Jahre |
Stéphane Burton | M | - |
Ghent University
| 1 Jahre |
Lieven Huysse | M | - |
Ghent University
| 3 Jahre |
Davy Ringoot | M | - |
Ghent University
| 5 Jahre |
Erik Mijten | M | - |
Ghent University
| 4 Jahre |
Mario Haneca | M | 52 |
Ghent University
| 4 Jahre |
Tom Almey | M | - |
Ghent University
| 4 Jahre |
Lieve Nuytinck | M | - |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | - |
Marc van Dijk | M | 61 |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 3 Jahre |
Filip Goossens | M | - |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 6 Jahre |
Isabelle Desmeytere | F | 48 |
Ghent University
| 4 Jahre |
Kristoff Jacky Andree Puelinckx | M | 54 |
Ghent University
| 6 Jahre |
Alain Bostoen | M | 54 |
Ghent University
| 3 Jahre |
Christian Cardon | M | 56 |
Ghent University
| 4 Jahre |
Lysiane Hauben | M | - |
Ghent University
| 3 Jahre |
Luc Vauterin | M | - |
Ghent University
| 3 Jahre |
Wim van Camp | M | - |
Ghent University
| 3 Jahre |
Nathalie Sierens | F | - |
Ghent University
| 4 Jahre |
Dany Vandevelde | M | - |
Ghent University
| 5 Jahre |
Kristel Verleyen | F | 53 |
Ghent University
| 3 Jahre |
Wim Ottevaere | M | 68 |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | 14 Jahre |
Davy Vandenheede | M | - |
Ghent University
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Belgien | 38 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Vera Goossens
- Persönliches Netzwerk